Nicolas A Menzies1, Andrea Parriott2, Sourya Shrestha3, David W Dowdy3, Ted Cohen4, Joshua A Salomon5, Suzanne M Marks6, Andrew N Hill6, Carla A Winston6, Garrett R Asay6, Pennan Barry7, Adam Readhead7, Jennifer Flood7, James G Kahn2,8, Priya B Shete9. 1. Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 2. Philip R. Lee Institute for Health Policy Studies. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut. 5. Department of Medicine, Stanford University, Palo Alto, California. 6. Division of Tuberculosis Elimination, CDC, Atlanta, Georgia; and. 7. Tuberculosis Control Branch, California Department of Public Health, Richmond, California. 8. Department of Epidemiology and Biostatistics, and. 9. Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California.
Abstract
Rationale: Mathematical modeling is used to understand disease dynamics, forecast trends, and inform public health prioritization. We conducted a comparative analysis of tuberculosis (TB) epidemiology and potential intervention effects in California, using three previously developed epidemiologic models of TB. Objectives: To compare the influence of various modeling methods and assumptions on epidemiologic projections of domestic latent TB infection (LTBI) control interventions in California. Methods: We compared model results between 2005 and 2050 under a base-case scenario representing current TB services and alternative scenarios including: 1) sustained interruption of Mycobacterium tuberculosis (Mtb) transmission, 2) sustained resolution of LTBI and TB prior to entry of new residents, and 3) one-time targeted testing and treatment of LTBI among 25% of non-U.S.-born individuals residing in California.Measurements and Main Results: Model estimates of TB cases and deaths in California were in close agreement over the historical period but diverged for LTBI prevalence and new Mtb infections-outcomes for which definitive data are unavailable. Between 2018 and 2050, models projected average annual declines of 0.58-1.42% in TB cases, without additional interventions. A one-time LTBI testing and treatment intervention among non-U.S.-born residents was projected to produce sustained reductions in TB incidence. Models found prevalent Mtb infection and migration to be more significant drivers of future TB incidence than local transmission.Conclusions: All models projected a stagnation in the decline of TB incidence, highlighting the need for additional interventions including greater access to LTBI diagnosis and treatment for non-U.S.-born individuals. Differences in model results reflect gaps in historical data and uncertainty in the trends of key parameters, demonstrating the need for high-quality, up-to-date data on TB determinants and outcomes.
Rationale: Mathematical modeling is used to understand disease dynamics, forecast trends, and inform public health prioritization. We conducted a comparative analysis of tuberculosis (TB) epidemiology and potential intervention effects in California, using three previously developed epidemiologic models of TB. Objectives: To compare the influence of various modeling methods and assumptions on epidemiologic projections of domestic latent TB infection (LTBI) control interventions in California. Methods: We compared model results between 2005 and 2050 under a base-case scenario representing current TB services and alternative scenarios including: 1) sustained interruption of Mycobacterium tuberculosis (Mtb) transmission, 2) sustained resolution of LTBI and TB prior to entry of new residents, and 3) one-time targeted testing and treatment of LTBI among 25% of non-U.S.-born individuals residing in California.Measurements and Main Results: Model estimates of TB cases and deaths in California were in close agreement over the historical period but diverged for LTBI prevalence and new Mtb infections-outcomes for which definitive data are unavailable. Between 2018 and 2050, models projected average annual declines of 0.58-1.42% in TB cases, without additional interventions. A one-time LTBI testing and treatment intervention among non-U.S.-born residents was projected to produce sustained reductions in TB incidence. Models found prevalent Mtb infection and migration to be more significant drivers of future TB incidence than local transmission.Conclusions: All models projected a stagnation in the decline of TB incidence, highlighting the need for additional interventions including greater access to LTBI diagnosis and treatment for non-U.S.-born individuals. Differences in model results reflect gaps in historical data and uncertainty in the trends of key parameters, demonstrating the need for high-quality, up-to-date data on TB determinants and outcomes.
Authors: Anthony T Fojo; Natalie L Stennis; Andrew S Azman; Emily A Kendall; Sourya Shrestha; Shama D Ahuja; David W Dowdy Journal: Lancet Public Health Date: 2017-07
Authors: Romain Ragonnet; James M Trauer; Nick Scott; Michael T Meehan; Justin T Denholm; Emma S McBryde Journal: Epidemics Date: 2017-06-16 Impact factor: 4.396
Authors: James D Mancuso; Jeffrey M Diffenderfer; Bijan J Ghassemieh; David J Horne; Tzu-Cheg Kao Journal: Am J Respir Crit Care Med Date: 2016-08-15 Impact factor: 21.405
Authors: Sourya Shrestha; Sarah Cherng; Andrew N Hill; Sue Reynolds; Jennifer Flood; Pennan M Barry; Adam Readhead; Margaret Oxtoby; Michael Lauzardo; Tom Privett; Suzanne M Marks; David W Dowdy Journal: Am J Epidemiol Date: 2019-09-01 Impact factor: 4.897
Authors: K G Castro; S M Marks; M P Chen; A N Hill; J E Becerra; R Miramontes; C A Winston; T R Navin; R H Pratt; K H Young; P A LoBue Journal: Int J Tuberc Lung Dis Date: 2016-07 Impact factor: 2.373
Authors: Nicolas A Menzies; Emory Wolf; David Connors; Meghan Bellerose; Alyssa N Sbarra; Ted Cohen; Andrew N Hill; Reza Yaesoubi; Kara Galer; Peter J White; Ibrahim Abubakar; Joshua A Salomon Journal: Lancet Infect Dis Date: 2018-04-10 Impact factor: 25.071
Authors: Suzanne M Marks; David W Dowdy; Nicolas A Menzies; Priya B Shete; Joshua A Salomon; Andrea Parriott; Sourya Shrestha; Jennifer Flood; Andrew N Hill Journal: Public Health Rep Date: 2020 Jul/Aug Impact factor: 2.792
Authors: Nicolas A Menzies; Sourya Shrestha; Andrea Parriott; Suzanne M Marks; Andrew N Hill; David W Dowdy; Priya B Shete; Ted Cohen; Joshua A Salomon Journal: Epidemiology Date: 2022-01-01 Impact factor: 4.822
Authors: Sourya Shrestha; Andrea Parriott; Nicolas A Menzies; Priya B Shete; Andrew N Hill; Suzanne M Marks; David W Dowdy Journal: Ann Am Thorac Soc Date: 2020-12
Authors: Nicolas A Menzies; Meghan Bellerose; Christian Testa; Nicole A Swartwood; Yelena Malyuta; Ted Cohen; Suzanne M Marks; Andrew N Hill; Anand A Date; Susan A Maloney; Sarah E Bowden; Ardath W Grills; Joshua A Salomon Journal: Am J Respir Crit Care Med Date: 2020-12-01 Impact factor: 21.405
Authors: Nicolas A Menzies; Nicole Swartwood; Christian Testa; Yelena Malyuta; Andrew N Hill; Suzanne M Marks; Ted Cohen; Joshua A Salomon Journal: Epidemiology Date: 2021-01 Impact factor: 4.860